These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8796309)

  • 21. Complex between the subtilisin from a mesophilic bacterium and the leech inhibitor eglin-C.
    Dauter Z; Betzel C; Genov N; Pipon N; Wilson KS
    Acta Crystallogr B; 1991 Oct; 47 ( Pt 5)():707-30. PubMed ID: 1793542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding, proteolytic, and crystallographic analyses of mutations at the protease-inhibitor interface of the subtilisin BPN'/chymotrypsin inhibitor 2 complex.
    Radisky ES; Kwan G; Karen Lu CJ; Koshland DE
    Biochemistry; 2004 Nov; 43(43):13648-56. PubMed ID: 15504027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
    Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
    Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NMR structure of CmPI-II, a non-classical Kazal protease inhibitor: Understanding its conformational dynamics and subtilisin A inhibition.
    Cabrera-Muñoz A; Valiente PA; Rojas L; Alonso-Del-Rivero Antigua M; Pires JR
    J Struct Biol; 2019 Jun; 206(3):280-294. PubMed ID: 30930219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. X-ray crystal structure of the bovine alpha-chymotrypsin/eglin c complex at 2.6 A resolution.
    Bolognesi M; Pugliese L; Gatti G; Frigerio F; Coda A; Antolini L; Schnebli HP; Menegatti E; Amiconi G; Ascenzi P
    J Mol Recognit; 1990 Aug; 3(4):163-8. PubMed ID: 2278733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The solution structure of eglin c based on measurements of many NOEs and coupling constants and its comparison with X-ray structures.
    Hyberts SG; Goldberg MS; Havel TF; Wagner G
    Protein Sci; 1992 Jun; 1(6):736-51. PubMed ID: 1304915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of the recombinant proteinase inhibitor eglin c from leech Hirudo medicinalis to human leukocyte elastase, bovine alpha-chymotrypsin and subtilisin Carlsberg: thermodynamic study.
    Ascenzi P; Amiconi G; Menegatti E; Guarneri M; Bolognesi M; Schnebli HP
    J Enzyme Inhib; 1988; 2(3):167-72. PubMed ID: 3071573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of the recombinant proteinase inhibitor eglin c from leech Hirudo medicinalis to serine (pro)enzymes: a comparative thermodynamic study.
    Ascenzi P; Aducci P; Amiconi G; Ballio A; Guaragna A; Menegatti E; Schnebli HP; Bolognesi M
    J Mol Recognit; 1991; 4(4):113-9. PubMed ID: 1799460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional tolerance of Streptomyces subtilisin inhibitor toward conformational and stability changes caused by single-point mutations in the hydrophobic core.
    Oda M; Tamura A; Kanaori K; Kojima S; Miura K; Momma K; Tonomura B; Akasaka K
    J Biochem; 2002 Dec; 132(6):991-5. PubMed ID: 12473203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequence-specific 1H NMR assignments and secondary structure of eglin c.
    Hyberts SG; Wagner G
    Biochemistry; 1990 Feb; 29(6):1465-74. PubMed ID: 2159339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The reactive site loop of the serpin SCCA1 is essential for cysteine proteinase inhibition.
    Schick C; Brömme D; Bartuski AJ; Uemura Y; Schechter NM; Silverman GA
    Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13465-70. PubMed ID: 9811823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure and function of subtilisin BPN' as studied through crystallographic studies on a series of its complexes with genetically engineered proteinaceous inhibitor SSI.
    Nonaka T; Suzuki T; Tanaka N; Saito S; Senda T; Miura K; Mitsui Y
    Adv Exp Med Biol; 1996; 379():21-7. PubMed ID: 8796307
    [No Abstract]   [Full Text] [Related]  

  • 33. S-ovalbumin, an ovalbumin conformer with properties analogous to those of loop-inserted serpins.
    Huntington JA; Patston PA; Gettins PG
    Protein Sci; 1995 Apr; 4(4):613-21. PubMed ID: 7613461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
    Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
    Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of the C-terminal region of yeast proteinase B inhibitor 2 in its inhibitory action.
    Kojima S; Deguchi M; Miura K
    J Mol Biol; 1999 Feb; 286(3):775-85. PubMed ID: 10024450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-range dynamic effects of point mutations propagate through side chains in the serine protease inhibitor eglin c.
    Clarkson MW; Lee AL
    Biochemistry; 2004 Oct; 43(39):12448-58. PubMed ID: 15449934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variability of the canonical loop conformations in serine proteinases inhibitors and other proteins.
    Apostoluk W; Otlewski J
    Proteins; 1998 Sep; 32(4):459-74. PubMed ID: 9726416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A serpin-induced extensive proteolytic susceptibility of urokinase-type plasminogen activator implicates distortion of the proteinase substrate-binding pocket and oxyanion hole in the serpin inhibitory mechanism.
    Egelund R; Petersen TE; Andreasen PA
    Eur J Biochem; 2001 Feb; 268(3):673-85. PubMed ID: 11168406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carboxyl proteinase from Pseudomonas defines a novel family of subtilisin-like enzymes.
    Wlodawer A; Li M; Dauter Z; Gustchina A; Uchida K; Oyama H; Dunn BM; Oda K
    Nat Struct Biol; 2001 May; 8(5):442-6. PubMed ID: 11323721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structures of native and complexed complement factor D: implications of the atypical His57 conformation and self-inhibitory loop in the regulation of specific serine protease activity.
    Jing H; Babu YS; Moore D; Kilpatrick JM; Liu XY; Volanakis JE; Narayana SV
    J Mol Biol; 1998 Oct; 282(5):1061-81. PubMed ID: 9753554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.